Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial

Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows a new revision label, v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record's metadata/versioning rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-06-05T12:03:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, signaling a new version of the page without changes to substantive content.
    Difference
    0.1%
    Check dated 2026-05-15T02:09:11.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.3, replacing the previous v3.5.2, indicating a minor update to the page's template or metadata. This change does not appear to alter the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-04-30T17:27:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:19:29.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:07.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is displayed on the page, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:15.000Z thumbnail image

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.